Australian-New Zealand Clinical Trial: In people with type 2 diabetes (T2D) and metabolic dysfunction-associated steatotic liver disease (MASLD), does exercise training improve liver fibro-inflammation?

Australia, Oct. 28 -- The Australian New Zealand Clinical Trials Registry (ANZCTR) received information related to the study titled ‘In people with type 2 diabetes (T2D) and metabolic dysfunction-associated steatotic liver disease (MASLD), does exercise training improve liver fibro-inflammation?’. The following are the other relevant details related to the trial:

Trial ID: 392696

Submit Date: 9/22/26 13:52

Study Type: Interventional

Intervention: What is the intervention: 12 weeks of supervised exercise training followed by 12 weeks of self-directed exercise training supported by one or more adherence building strategies. Supervised Phase (12 wks)- Three supervised sessions/week with an exercise professional including (i) two session of...